Deal snapshot: 22nd Century Group Acquires GVB Biopharma to Expand in Hemp/Cannabis Ingredient Market.

MANews-(C)2009-2022

New York-based agricultural biotechnology company 22nd Century Group, Inc. (NASDAQ: XXII) has acquired Nevada-based hemp/cannabis company GVB Biopharma to expand assets to serve the hemp/cannabis ingredient market, the company said.

The aggregate consideration for the transaction consisted of the assumption of...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT